Generics

Innovative

Biosimilars Products found!

Medical devices

Nutraceuticals

Filters

Tirzepatide manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

3 products found

tirzepatide

Injection 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #1338

The company is a prominent player in the generic pharmaceutical industry with strong capabilities in research, development, manufacturing, and commercialization. It has received multiple GMP certifications from international regulatory bodies, such as those from Bavaria, Switzerland, Slovenia, and Mexico, underscoring its commitment to quality and global standards. Recognized for its innovation, the company has earned numerous product patents and prestigious awards, such as the Pharmexcil Patent Award. With ISO certifications for quality and environmental management, a robust infrastructure of five manufacturing facilities in India, and strategic partnerships for producing HIV/AIDS drugs, the company demonstrates a strong focus on expanding its global footprint and delivering affordable healthcare solutions.

Manufacturer usually replies in 19 days

tirzepatide

Injection, pre-filled pen 2.5 mg/0.5 ml, 5 mg/0.5 ml, 7.5 mg/0.5 ml, 10 mg/0.5 ml, 12.5 mg/0.5 ml, 15 mg/0.5 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA, Canada
Comments
Dossier availability: North America, Canada, Europe, United Kingdom, Latin America, Emerging MarketStorage: 2 - 8 C
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 37 days

tirzepatide

Injection, pre-filled pen 2.5 mg/0.5 ml, 5 mg/0.5 ml, 7.5 mg/0.5 ml, 10 mg/0.5 ml, 12.5 mg/0.5 ml, 15 mg/0.5 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA, Canada
Comments
Dossier availability: North America, Canada, Europe, United Kingdom, Latin America, Emerging MarketStorage: 2 - 8 C
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 37 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.